Robert Corringham
Plus aucun poste en cours
Profil
Robert Corringham served as President of Centocor, Inc. and held senior positions at Ambit Biosciences Corp.
and Bionomics Ltd.
He was also a Professor at the University of Toronto and the University of California San Diego.
Additionally, he was a Director at GlaxoSmithKline Australia Pty Ltd.
and the University of California, Davis.
He served as Vice President-Clinical Development at Astex Pharmaceuticals, Inc. and Chief Medical Officer at Triphase Accelerator Corp.
Corringham earned a doctorate degree from the University of London.
Anciens postes connus de Robert Corringham
| Sociétés | Poste | Fin |
|---|---|---|
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Directeur Technique/Scientifique/R&D | 01/05/2012 |
| University of California San Diego | Corporate Officer/Principal | - |
| University of Toronto | Corporate Officer/Principal | - |
Triphase Accelerator Corp.
 Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Directeur Technique/Scientifique/R&D | - |
Glaxosmithkline Australia Pty Ltd.
 Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia. | Directeur/Membre du Conseil | - |
Formation de Robert Corringham
| University of London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIONOMICS LIMITED | Health Technology |
| Entreprise privées | 7 |
|---|---|
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
The University of Ottawa Heart Institute
 The University of Ottawa Heart Institute Hospital/Nursing ManagementHealth Services The University of Ottawa Heart Institute operates as a health center to understand, treat, and prevent heart disease. The firm's clinical departments include clinical care, cardiology, cardiac imaging, cardiac surgery, cardiac anesthesiology, cardiac prevention and rehabilitation, clinical services, biomedical engineering and diagnostic services. The company was founded in 1976 and is headquartered in Ottawa, Canada. | Health Services |
| Princess Margaret Hospital | |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
Glaxosmithkline Australia Pty Ltd.
Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia. | Health Technology |
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Health Technology |
